All In Biotech

Drug Trial Radar · NCT05050136

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis

Last checked: Nov 19, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 333 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

333

Actual

Start

Sep 22, 2021

Primary completion

Jan 2027

Study completion Dec 2028

Sponsor

Lead sponsor
Mirum Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Sep 20, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.

Conditions

  • Primary Biliary Cholangitis
  • PBC

Interventions

  • VolixibatDrug

    Oral capsules, administered twice daily. Volixibat is an Ileal Bile Acid Transporter (IBAT) inhibitor.

  • PlaceboDrug

    Capsules matched to study drug without the active pharmaceutical ingredient

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change in the daily itch scores using the Adult Itch Reported Outcome (Adult ItchRO) questionnaireTime frame: Baseline to week 28

Locations

130 sites in 15 countries. Site status is shown where the registry gives one.

  • Southern California Research Center

    Coronado, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • University of California Los Angeles

    Los Angeles, California

  • UC Davis

    Sacramento, California

  • University of Colorado

    Aurora, Colorado

  • Yale University Digestive Diseases

    New Haven, Connecticut

  • Covenant Metabolic Specialists

    Fort Myers, Florida

  • UF Hepatology Research at CTRB

    Gainesville, Florida

  • UF Health Gastroenterology- Emerson

    Jacksonville, Florida

  • IHS Health

    Kissimmee, Florida

  • Schiff Center for Liver Diseases

    Miami, Florida

  • Advanced Research Institute, Inc

    New Port Richey, Florida

  • Covenant Research and Clinics, LLC

    Sarasota, Florida

  • Tampa General Hospital

    Tampa, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • Southeast Clinical Research Center

    Dalton, Georgia

  • Northwestern University

    Chicago, Illinois

  • Loyola University Health System - Loyola Outpatient Center

    Maywood, Illinois

  • University of Iowa Hospitals & Clinics

    Iowa City, Iowa

  • Ochsner Clinic Foundation-Baton Rouge

    Baton Rouge, Louisiana

  • LSU Health Science Center Shreveport

    Shreveport, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Beth Israel Deaconess

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • Jackson Liver and GI Specialists

    Jackson, Mississippi

  • CHI Health Clinic (Alegent Creighton Clinic)- Gastroenterology-Bergan

    Omaha, Nebraska

  • Virtua Center for Liver Disease-Camden

    Camden, New Jersey

  • Montefiore Medical Center

    The Bronx, New York

  • Science 37, Inc (Remote-homebased Telemedicine)

    Morrisville, North Carolina

  • Cleveland Clinic - Main Campus

    Cleveland, Ohio

  • Einstein Healthcare Network - Einstein Medical Center

    Philadelphia, Pennsylvania

  • Methodist Le Bonheur Healthcare

    Memphis, Tennessee

  • Galen Medical Group, P.C

    Tennessee City, Tennessee

  • Amel Med LLC

    Austin, Texas

  • The Liver Institute at Methodist Dallas Medical Center

    Dallas, Texas

  • Soma Clinical Trials

    Denison, Texas

  • Baylor College of Medicine

    Houston, Texas

  • Liver Associates of Texas

    Houston, Texas

  • Impact Research

    Waco, Texas

  • University of Utah Health Care

    Salt Lake City, Utah

Showing 40 of 130 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.